Back to All
Group

Podcast: Diaceutics CEO Peter Keeling interviewed on RTE Radio 1 about latest £4m funding round from Silicon Valley Bank & Precision Medicine

27 August, 2020

Peter Keeling, CEO of Diaceutics discusses their latest £4m funding round from Silicon Valley Bank and explains the vision of Diaceutics in getting the right treatments to the right patients through advancing Precision Medicine.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.